Webert et al used the Bleeding Severity Measurement Scale (BSMS) to describe bleeding in a patient with chemotherapy-induced thrombocytopenia. The authors are from McMaster University and the Canadian Blood Service.
Groups:
(1) not clinically significant
(2) clinically significant
Clinical Status
Severity
Code
no bleeding at all
none
0
minimal with no impact on patient, may be detected only by laboratory testing
trace
1a
present but not clinically significant with no impact on patient, does not influence care
mild
1b
any significant bleeding that: (a) causes pain that has to be treated, (b) prompts a therapeutic intervention like blood transfusion or surgery, (c) results in closer monitoring or an invasive study
serious
2a
any significant bleeding that: (a) involves CNS, (b) results in vision loss, (c) causes hemodynamic instability, (d) causes any other morbidity
serious with moribidity
2b
cause of death
fatal (serious with mortality)
2c
To read more or access our algorithms and calculators, please log in or register.
